Cargando…

OPTC-1. Proteomic analysis of genetically stratified low-grade meningioma

INTRODUCTION: Meningioma are the most common primary intracranial tumour. According to WHO, ~80% tumours are benign grade I. Although, some grade I tumour clinically show aggressive behaviour. Radio-surgery are the main therapeutic approaches, chemotherapies are ineffective. Accurate biomarkers for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Akther, Yeasmin, Adams, Claire, Sharma, Vikram, Barros, Claudia, Banton, Matthew, Hanemann, Oliver
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Supplement Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8255455/ http://dx.doi.org/10.1093/noajnl/vdab070.022

Ejemplares similares

OPTC-5. Molecular signatures of podoplanin expressing glioblastoma cell subsets with putative role in cancer associated thrombosis and microthrombosis
por: Tawil, Nadim, et al.
Publicado: (2021)

OPTC-4. Bioinformatic analysis of COLXIα1 gene expression and its alternative splicing regulation in Paediatric Diffuse Intrinsic Pontine Gliomas (DIPGs)
por: Jedrysik, Malwina, et al.
Publicado: (2021)

Global Proteome and Phospho-proteome Analysis of Merlin-deficient Meningioma and Schwannoma Identifies PDLIM2 as a Novel Therapeutic Target
por: Bassiri, Kayleigh, et al.
Publicado: (2017)

An evaluation of OPTC and EPYC as candidate genes for high myopia
por: Wang, Panfeng, et al.
Publicado: (2009)

2nd International Conference on Optcs and Laser Applications
Publicado: (2007)

Proteomic analysis discovers the differential expression of novel proteins and phosphoproteins in meningioma including NEK9, HK2 and SET and deregulation of RNA metabolism
por: Dunn, Jemma, et al.
Publicado: (2018)

GATA-4, a potential novel therapeutic target for high-grade meningioma, regulates miR-497, a potential novel circulating biomarker for high-grade meningioma
por: Negroni, Caterina, et al.
Publicado: (2020)

10031-RT-02 Results of reactor-based BNCT for 44 cases of recurrent and refractory high-grade meningiomas and road to accelerator based BNCT
por: Miyatake, Shin-Ichi, et al.
Publicado: (2020)

TB-03 Newly Established Meningioma Organoid Model Elucidated an Important Role of FOXM1 in Meningioma Progression
por: Yamazaki, Shintaro, et al.
Publicado: (2020)

Spinal meningiomas
por: Hohenberger, Christoph, et al.
Publicado: (2023)

Fibulin-2: A Novel Biomarker for Differentiating Grade II from Grade I Meningiomas
por: Sofela, Agbolahan A., et al.
Publicado: (2021)

The joint impacts of sex and race/ethnicity on incidence of grade 1 versus grades 2–3 meningioma across the lifespan
por: Walsh, Kyle M, et al.
Publicado: (2023)

Integration and Comparison of Transcriptomic and Proteomic Data for Meningioma
por: Dunn, Jemma, et al.
Publicado: (2020)

TB-06 Eribulin prolongs survival in an orthotopic xenograft mouse model of malignant meningioma
por: Nakano, Tomoyuki, et al.
Publicado: (2020)

OTME-23. Single-cell transcriptomic and epigenomic immune landscape of isocitrate dehydrogenase stratified human gliomas
por: Gupta, Pravesh, et al.
Publicado: (2021)

ET-7 Roles for hENT1 and dCK in gemcitabine sensitivity and malignancy of meningioma
por: Yamamoto, Masahiro, et al.
Publicado: (2021)

ET-6 Gemcitabine radiosensitization primes irradiated malignant meningioma cells for senolytic elimination by navitoclax
por: Yamamoto, Masahiro, et al.
Publicado: (2021)

TB-2 Patient-derived meningioma organoid model demonstrates FOXM1 dependent tumor proliferation
por: Yamazaki, Shintaro, et al.
Publicado: (2021)

OTEH-3. Targeted Gene-Expression analysis during malignant transformation in primary and secondary malignant meningioma
por: Maier, Andrea Daniela, et al.
Publicado: (2021)

NI-04 Evaluation of post boron neutron capture therapy for recurrent meningioma using fluoride-labeled boronophenylalanine PET
por: Takai, Satoshi, et al.
Publicado: (2020)

Meningioma in the elderly
por: Amoo, Michael, et al.
Publicado: (2023)

The clinical, genetic, and immune landscape of meningioma in patients with NF2-schwannomatosis
por: Gregory, Grace E, et al.
Publicado: (2023)

COT-16 Development of automatic lesion extraction application using artificial intelligence for the purpose of simplifying tumor volume measurement of meningioma
por: Hirayama, Ryuichi, et al.
Publicado: (2021)

NI-6 Preoperative differential diagnosis of grade II and grade III in cases with astrocytoma, IDH mutant
por: Yano, Hirohito, et al.
Publicado: (2021)

Evaluation of the OPTC gene in primary open angle glaucoma: functional significance of a silent change
por: Acharya, Moulinath, et al.
Publicado: (2007)

OTME-5. Meningioma liquid biopsy specimens exhibit contrasting immune-cell landscapes across methylation-subtypes and estimated recurrence risk subgroups
por: Herrgott, Grayson, et al.
Publicado: (2021)

Radiotherapy and radiosurgery for meningiomas
por: Chen, William C, et al.
Publicado: (2023)

ECOA-9. Integration of molecular and methylation classifications yields three meningioma groups and suggests chromosome 1p loss may be critical to the aggressive group
por: Bayley, James, et al.
Publicado: (2021)

FSMP-05. KETOGENIC DIETS FOR HIGH-GRADE GLIOMA
por: Immidisetti, Amanda, et al.
Publicado: (2021)

BIMG-04. MAPPING HETEROGENEITY OF HIGH-GRADE GLIOMA METABOLISM USING HIGH RESOLUTION 7T MRSI
por: Hangel, Gilbert, et al.
Publicado: (2021)

OMRT-6. Optimizing MDM2 inhibition for the treatment of high-grade glioma
por: Rendo, Veronica, et al.
Publicado: (2021)

The clinical and genomic features of seizures in meningiomas
por: Dincer, Alper, et al.
Publicado: (2023)

Advances in PET imaging for meningioma patients
por: Galldiks, Norbert, et al.
Publicado: (2023)

Multiple meningiomas: Epidemiology, management, and outcomes
por: Fahlström, Andreas, et al.
Publicado: (2023)

ACT-5 Prognosis of IDH-mut lower-grade gliomas in Hokkaido University Hospital
por: Yamaguchi, Shigeru, et al.
Publicado: (2021)

MPC-4 Malignant transformation of diffuse low-grade gliomas: systematic review and meta-analysis
por: Nakasu, Satoshi, et al.
Publicado: (2021)

The management of incidental meningioma: An unresolved clinical conundrum
por: Islim, Abdurrahman I, et al.
Publicado: (2023)

NI-10 T2/FLAIR mismatch sign and methionine PET uptake in grade II and III gliomas
por: Ebiko, Yusuke, et al.
Publicado: (2020)

ACT-17 Protocol design of a matrix-type of novel clinical trial for lower-grade gliomas
por: Muragaki, Yoshihiro, et al.
Publicado: (2020)

MPC-2 Clinical course and prognosis of lower-grade glioma, IDH wildtype and pTERT mutant
por: Takahashi, Yoshinobu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jko8c6lmncjp16j53rvv1c57mh